Proteogenomic and metabolomic characterization of human glioblastoma

Wang, Liang-Bo, Karpova, Alla, Gritsenko, Marina A., Kyle, Jennifer E., Cao, Song, Li, Yize, Rykunov, Dmitry, Colaprico, Antonio +230 more·2021·Cancer Cell
DOI 10.1016/j.ccell.2021.01.006

Cited by (656)

Items 601–656 of 656

  1. Dual Regulation of Post-Translational Modification of Proteins: Bottlenecks and Breakthroughs in NK Cell Therapy for Glioblastoma
    Yushu Liu, Qingya Qiu, Hui Deng, Ping Song, Jiarui Bu, Mengxian Zhang · 2026 · International Journal of General Medicine
  2. Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to Chemoradiotherapy
    Andra Valentina Krauze, Trinh Nguyen, Michael L. Sierk, Luke R. Jackson, Shreya Chappidi, Qingrong Chen, Chunhua Yan, Ying Hu, Stephanie A. Harmon, Erdal Taşçı et al. · 2026 · Research Square
  3. Changes of major genes related to cellular senescence in glioma
    Nives Pećina‐Šlaus, Jan Težak, Klaudia Babić, Andrija Štajduhar, Reno Hrašćan · 2026 · Research Square
  4. Proteogenomics: decoding cancer in multiple dimensions
    Qian Liu, Yuehua Chen, Hu Zhou · 2026 · MedScience
  5. ITPKA suppresses glioma progression and predicts patient prognosis
    Naiyue Zhang, Min Peng, Jun Liu, Shizhang Ling · 2026 · Frontiers in Oncology
  6. AI-driven network pharmacology and multi-omics validation identify KCNH2 as a prognostic biomarker and candidate therapeutic vulnerability of Acorus tatarinowii in glioblastoma
    Xiaoqing Song, Yuanyang Xiao, Junhui Liu, Shanshan Wei, Meijuan Tan, Yuanyuan Chen, Xiaohong Yu · 2026 · Frontiers in Pharmacology
  7. A Proteome-Calibrated Mechanistic Digital Twin of the Glioblastoma Astrocyte Derived from Patient Multi-Omic Data
    John D. Mayfield · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  8. MultiOmicsXplorer, a tool to browse, access and analyse multi-omics data
    Eleonora Meo, Veronica Lombardi, Veronica Venafra, Valerio Licursi, Francesca Sacco, Livia Perfetto · 2026 · BMC Bioinformatics
  9. Mass Spectrometric Detected Cancer Proteins as Resources for Cancer Research
    Yuanyu Huang, Lijun Chen, Peter I-Fan Wu, Poorva Juneja, Li Chen, Yvonne A. Evrard, Liyuan Jiao, Yingwei Hu, Xu Zhang, James H. Doroshow et al. · 2026 · Journal of Proteome Research
  10. The proteasome activator subunits PA28α and PA28β have unique molecular roles in glioblastoma
    Samuel Weiss, Kyle Heemskerk, Ravinder Kaur Bahia, Samir Assaf, Xiaoguang Hao, Fatima Hamood, Gayatri Dronamraju, Rozina Hassam, Orsolya Cseh, Bruno N. Melillo et al. · 2026 · Research Square
  11. Cellular senescence escape and antiviral response discriminate glioblastoma from lower-grade gliomas
    Dominika Maurencova, Michaela Šadibolová, Monika Žárská, Zuzana Liblova, Josef Novak, Jiřina Kroupová, Pavla Vašicová, Jiri Bartek, Zdeněk Hodný · 2026 · Neuro-Oncology Advances
  12. Chemical screens identify HDAC6 as an epigenetic vulnerability in acquired Temozolomide-resistant models of glioblastoma
    Feridun Aksu, Buse Cevatemre, Nareg Pinarbasi Degirmenci, Ezgi Yağmur Kala, Duygu Uçku, Martin Philpott, Adam P. Cribbs, James E. Dunford, Udo C. T. Oppermann, Ceyda Açılan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Uncovering dark biomarkers of glioblastoma survival through regulatory-deviation–based transcriptomic modeling
    Yangyu Ning, Zijun Qu, Zehang Xie, Shujun Wan, Weiya Pei, Xueqin Li, Mengying Zhang, Xiaolong Zhu, Lei Li, Kun Lv · 2026 · Research Square
  14. BRAF-amplified glioblastoma patients have a worse prognosis than those with BRAF mutation and are associated with amplification of MET, RHEB and CUL1
    Rong Da, Maode Wang, Haitao Jiang, Wei Wang · 2026 · BMC Neurology
  15. Integrated proteomic and single-nucleus transcriptomic profiling identifies prognostic markers and therapeutic targets in glioblastoma
    Chengyong Yang, Junchi Luo, Sha Yang, Mei Deng, Tao Xiong, Junheng Zhang, Wenjing Yang, Jiqin Zhang, X Y Xiang, Liangzhao Chu et al. · 2026 · Discover Oncology
  16. CSIE: cancer subtyping via inference and ensemble
    Dieu Tran, Yen Thi‐Hai Pham, Hung Nguyen Luu, Juli Petereit, Manuel A Andrade-Rodriguez, Phi Bya, Tin Nguyen · 2026 · Briefings in Bioinformatics
  17. Histone methylation machinery in gliomas: From enzymatic mechanisms to inhibitor development
    X C Wang, Wenqi Liu, Jie Sun, Xiuhong Wei, Zengyong Wang, Lanlan Zang · 2026 · Cancer Treatment and Research Communications
  18. Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
    Guilong Tanzhu, Liu Chen, Jiao-Yang Ning, Gang Xiao, Su Wen, Ce Wang, Hao Wen, Ke-Qin Zhang, Jie Yang, Mu-yuan Jia et al. · 2026 · Military Medical Research
  19. A Patient-Derived Glioblastoma Organoid Model that Preserves Intra- and Intertumoral Heterogeneity
    Melis Erçelik, Çağla Tekin, Pınar Eser Ocak, Ahmet Bekâr, Hasan Kocaelı, Mevlüt Özgür Taşkapılıoğlu, Berrin Tunca · 2026 · Online Türk Sağlık Bilimleri Dergisi
  20. From cold to responsive: IFN-α treatment is associated with collagen VI remodeling and enhanced anti-PD-1 efficacy in Well-/dedifferentiated liposarcoma
    Aobo Zhuang, Zhe Xi, Xu Chengfei, Jie Liu, Yingxue Cheng, Xiao Zhou, Zhang Chenhe, Yuehua Chen, Aojia Zhuang, Xueling Wang et al. · 2026 · Genes & Diseases
  21. Gene expression profiling enables refined parcellation of cortical layers in the heterogeneous human cerebral cortex
    Yanrong Wei, Youzhe He, Yuyang Liu, Langjian Zhu, Tiannan Feng, Zhiming Shen, Wu Wei, Longqi Liu, Lei Han, Lifang Wang · 2026 · Genome Medicine
  22. Integrated analysis of amide proton transfer weighted MRI and proteomics uncovers altered protein dynamics in glioblastoma
    Xinran Yan, Andong Ma, Ni Zeng, Xia Zou, Zhu J, Yaoming Qu, Zhibo Wen · 2026 · Neuroradiology
  23. Small-RNA Profiling Links 5’-tRNA Halves to Post-therapeutic Disease Persistence and Poor Patient Survival in Glioblastoma
    Monima Anam, Taylor L. Schanel, Sophia Dunlap, Mostafa Mohamed, Eun-Young Erin Ahn, Christopher Douglas Willey, Zhangli Su · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Data-driven registration and modeling of brain deformation for image-guided neurosurgery
    Tiago Assis, Colin Galvin, Joshua P. Castillo, Nazim Haouchine, Marta Kersten‐Oertel, Zeyu Gao, Mireia Crispin‐Ortuzar, Stephen J. Price, Thomas Santarius, Yangming Ou et al. · 2026 · Medical Image Analysis
  25. Lipid metabolic plasticity in glioblastoma: mechanisms, tumor microenvironment remodeling, and therapeutic opportunities
    Weiqi Wu, M M Liu, Qi Lv, Zixun Ming, Longchang Song, Junsheng Chu · 2026 · Frontiers in Oncology
  26. Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort
    Katharina Johanna Weber, Jürgen Hench, Markus Zumpt, Thomas Eska, Moritz Armbrust, Pia Susann Zeiner, Tabea Isabelle Hartung, Viktoria Ruf, Eike Steidl, Mareike Dettki et al. · 2026 · Acta Neuropathologica Communications
  27. The Unsaturated/Saturated Fatty Acid Ratio: A Metabolic Hub and Therapeutic Vulnerability in Glioblastoma
    Xuhao Dai, Jialin Ku, Haixiang Li, Runxi Yan, Baofeng Wang · 2026 · Biomedicines
  28. Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study
    Metka Novak, Bernarda Majc, Marija Skoblar Vidmar, Špela Kladnik, Tina Kolenc Milavec, Anamarija Habič, Simona Katrin Galun, Pia Žižek, Andrej Porčnik, Alenka Matjašič et al. · 2026 · Biomedicine & Pharmacotherapy
  29. Opposing kinase signaling may underlie the inverse relationship between cancer and Alzheimer's disease
    Joyce Fang, Xinkun Wang · 2026 · Journal of Proteomics
  30. Revisiting brachytherapy: Balancing cell death and antioxidant defense in glioblastoma treatment
    Xueda Li, Chuan Tian, Wenshe Sun, Wei Zhang, Lili Yang, Bin Liu, Peng Jiang, Dongming Xing, Congxiao Wang, Xiaokun Hu · 2026 · Journal of Cancer Research and Therapeutics
  31. Sevoflurane is associated with reduced EGFR-VEGF-AKT signaling in glioma tissues relative to propofol: a bioinformatics and clinical pilot study
    Qian Hu, Feng Lu, Jiasheng Wang, Rui-Yang Cao, Wen-Kai Liu, Mingling Guo, Yong Lin, Maolin Zhong, Wei-Dong Liang, Lifeng Wang · 2026 · Frontiers in Oncology
  32. Exposure-aware multi-omics and artificial intelligence for biomarker discovery and precision prevention in diffuse glioma
    Suming Zhang, Zhilin Si, Na Yang, Xin Chen · 2026 · Frontiers in Immunology
  33. An inverse neural-identity/immune-escape axis defines glioma prognosis: a multi-cohort machine-learning signature (NAIES)
    Kaihua Cao, Zhihua CHENG, Yu Zeng, Wenchuan Zhang · 2026 · SSRN Electronic Journal
  34. Pan-Cancer Metabolic Landscapes: A Multiomics View
    Yiguang Bai, Qiaoling Chen, Y. D. Li · 2026 · Journal of Proteome Research
  35. Curculigoside suppresses glioblastoma progression through the EGFR/MMP2 axis: evidence from network pharmacology and experimental validation
    Jiawen Han, Zhanchuan Ma, Shan Lin, Wei Wu · 2026 · Bioorganic Chemistry
  36. A Transcriptome-Wide Analysis Nominates DIO3OS and C9orf139 as Survival-Associated Long Non-Coding RNAs in Glioblastoma
    Minseon Kim, Seung-Kyoon Kim, Jaeil Han · 2026 · Non-Coding RNA
  37. TMEM164 mRNA in Adult Glioblastoma: Multicohort Overexpression and RIPK1 Co-Expression Without Prognostic Replication
    Flavio Donnini, Cristiana Bellan, Sergio Antonio Tripodi, Lucia Mundo, Paolo Tini · 2026 · Brain Sciences
  38. Neural–metabolic crosstalk governing cell death and therapy resistance in tumors
    Yiming Yan, Haojie Sun, Ziqiang Liu, Chandra Sekhar Bhol, Gautam Sethi, Wenhua Xue, Lifeng Li · 2026 · Pharmacological Research
  39. Precision prognostication in glioblastoma, IDH‑wildtype through multi‑cohort validation of genomic alterations
    Yongjae Kim, Seong-Eun Kim, Ji Eun Park, Chang Ohk Sung, Do Kyung Yoon, Dohoon Park, Soo Jeong Nam, Sang Woo Song, Chang‐Ki Hong, Young-Hoon Kim et al. · 2026 · Acta Neuropathologica Communications
  40. Effective tumor kinetics inferred from single routine H&E biopsies enable counterfactual virtual radiotherapy trials
    Pirmin Schlicke, Caner Ercan, Sara Ranjbar, Ashlee Nichole Seldomridge, Sadhna Aggarwal, Adwait Mehta, Tania P. Sainz, Mohammad U. Zahid, Penny Q. Fang, Veronika A. Hofmann et al. · 2026 · medRxiv
  41. Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets
    Nicole L. Tignor, Mateusz Koptyra, Shrabanti Chowdhury, Francesca Petralia, Marina Gritsenko, Weiping Ma, Yuankun Zhu, Giacomo B. Marino, Xiaoyu Song, Simona Migliozzi et al. · 2026 · Cell Reports Medicine
  42. C1q from C1q + tumor-associated myeloid cells promotes resistance to T-cell engagers and CAR T-cells and is induced by LIF and glucocorticoids
    María López Vázquez, Sergio Espinosa-Gil, Raffaella Iurlaro, Laura Carrillo Bosch, Ariadna Grinyo i Escuer, Dario Solis Sayago, Alexandra Arias, Isabel Cuartas, Almudena Neva-Alejo, Laia Cuesta‐Casanovas et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Integrated bioinformatics analysis of chromosomal deletion regions in glioblastoma identifies key genes linked to GABA(A) receptor signaling
    Hasan Onur Çağlar, Berkay Meral, Fulya Çağlar · 2026 · Journal of Biomolecular Structure and Dynamics
  44. What’s next for metabolomics?
    Nichole A. Reisdorph, Corey D. Broeckling, Rafael Brüschweiler, Clary B. Clish, Valérie Copié, Timothy M. D. Ebbels, Arthur S. Edison, Facundo M. Fernández, Ulrich L. Günther, Ewy A. Mathé et al. · 2026 · Current Opinion in Biotechnology
  45. Functional proteomic and phosphoproteomic profiling of routine FFPE CNS tumor tissue complements genomic and epigenomic characterization
    Dennis Friedel, Rhaissa Ribeiro da Silva, Ivan Abdulrazak, Beatriz Martins Wolff, Anna Neuerburg, Ramona Irsevic, Shiva Ahmadi, Ashok Kumar Jayavelu, Andreas E. Kulozik, Olaf Witt et al. · 2026 · Acta Neuropathologica
  46. Lipid-autophagy crosstalk in glioblastoma: A context-dependent stress-adaptation interface under temozolomide pressure
    Mehdi Eshraghi, Ivan Iurchenko, Amir Barzegar Behrooz · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  47. Breaking adaptive oncogenic resistance in glioblastoma via targeting the EGFR–STAT3 axis
    Nisar Ahmad, Arfan Ullah · 2026 · Medical Oncology
  48. CEBPB integrates OSM signaling and eIF4G2-mediated alternative translation to configure enhancer landscape and sustain oncogenic CHI3L1 in glioblastoma
    Jiyang Liu, Ying Zhang, Xiaoping Yi, Long Xie, Xingze Huang, Zhipeng Zhu, Zhongyuan Zhang, Jing Wang, Suya Zheng, Yongjie Wang et al. · 2026 · Neuro-Oncology
  49. NeuroMetBench: patient-aware evidence bounds for transcript-derived metabolic representations across cancer proteogenomic contexts
    Abdsalam Bitar · 2026 · Functional & Integrative Genomics
  50. Integrating proteomics to map immune landscape and protein biomarkers for risk stratification in childhood Langerhans cell histiocytosis
    Jin Liu, Huizhuang Shan, Jiaguo Yuan, Weina Zhang, Qingqing Zheng, Haiyan Liu, Pengfei Wang, 林慧玲, Caiyun Kuang, Meifen Huang et al. · 2026 · Frontiers in Immunology
  51. Sequence space exploration in SHP2: mechanistic insights from disease-associated mutations
    Anne E. van Vlimmeren, Ziyuan Jiang, Devon A. Semoy, Neel H. Shah · 2026 · Biochemical Journal
  52. Western Blot analysis of several proteins selected based on CAGE sequencing results (associated data for: Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression)
    Żaneta Kałuzińska‐Kołat, Damian Kołat, Elżbieta Płuciennik · 2026 · Zenodo (CERN European Organization for Nuclear Research)
  53. Data from: Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
    Żaneta Kałuzińska‐Kołat · 2024 · Zenodo (CERN European Organization for Nuclear Research)
  54. Example Data for iModMix
    Isis Yanina Narvaez-Bandera · 2024 · Zenodo (CERN European Organization for Nuclear Research)
  55. Isoform‐Specific KPNA Associations With Malignant Transcriptional Programs in Glioblastoma: A Multi‐Cohort Transcriptomic Analysis
    Hirotaka Nomiya, Yasunari Nakamoto, Masami Yamada · 2026 · Computational and Systems Oncology
  56. Clinical proteomics of glioblastoma: Functional states and the question of plasticity
    Stephanie B. Telerman · 2026 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics